Merck/Celltech
Executive Summary
Agree to collaborate on the "long-term identification and development of a novel oral treatment for arthritis" which will "inhibit the arthritic process itself." Based in the United Kingdom, Celltech reports it has already isolated natural inhibitors to the human enzymes believed responsible for the disease.